Bangkok Genomics Innovation PCL engages in the provision of screening services for fetal chromosomal abnormalities. It offers screening for genetic abnormalities, analysis infectious disease group, cancer related screening, genetic code analysis with whole exome sequencing, individual genetic testing, newborn screening, basic health check-up, providing technology services and other medical products. The company was founded in 2017 and is headquartered in Bangkok, Thailand.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company